Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon -- Ignore unavailable to you. Want to Upgrade?

To: mopgcw who wrote (2303)	9/25/2013 12:16:44 PM
From: scaram(o)uche	Respond to of 2344

FDA must have established conditions for that SPA after having consulted with TS.com. Merck executives are continuing and extending tests of the vaccine which should provide insight that extends well beyond nsclc, but Feuerstein would prefer that the trial be viewed as desperation. I noticed that both the twit-journalists and the twit-statisticians are out, hoping yet again that a cancer trial will fail. The one guy who we KNOW increased his position at the bottom??........ CONGRATULATIONS, STEVE!